Search

Your search keyword '"D. Di Giuseppe"' showing total 28 results

Search Constraints

Start Over You searched for: Author "D. Di Giuseppe" Remove constraint Author: "D. Di Giuseppe" Topic business Remove constraint Topic: business
28 results on '"D. Di Giuseppe"'

Search Results

1. POS1169 IMPACT OF THE COVID-19 PANDEMIC ON MORBIDITY AND MORTALITY AMONG SWEDISH PATIENTS WITH INFLAMMATORY JOINT DISEASES VERSUS THE GENERAL POPULATION

2. OP0222 THE INCIDENCE OF INTERSTITIAL LUNG DISEASE IN PSORIATIC ARTHRITIS COMPARED TO RHEUMATOID ARTHRITIS. DATA FROM OVER 89 000 BDMARD TREATMENT COURSES DERIVED FROM FIVE NORDIC REGISTERS

Catalog

Books, media, physical & digital resources

3. OP0140 BIOLOGIC REFRACTORY DISEASE IN AXIAL SPONDYLOARTHRITIS - DEFINITION, PREVALENCE AND PATIENT CHARACTERISTICS. A COLLABORATION BETWEEN FIVE NORDIC BIOLOGIC REGISTRIES

4. OP0109 CO-MEDICATION WITH A CONVENTIONAL SYNTHETIC DMARD IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS IS ASSOCIATED WITH IMPROVED RETENTION OF TNF INHIBITORS: RESULTS FROM THE EUROSPA COLLABORATION

5. FRI0275 ONE-YEAR TREATMENT RETENTION OF SECUKINUMAB VERSUS TUMOR NECROSIS FACTOR INHIBITORS IN SPONDYLOARTHRITIS. RESULTS FROM FIVE NORDIC BIOLOGIC REGISTRIES

6. Authors' reply

7. AB0054 IS TEA CONSUMPTION ASSOCIATED WITH RISK OF RHEUMATOID ARTHRITIS?

8. OP0218 MORTALITY IN PATIENTS WITH PSORIATIC ARTHRITIS IN SWEDEN

9. POS0601 DIFFERENCES IN DRUG SURVIVAL BETWEEN ORIGINATOR AND BIOSIMILAR PRODUCTS AMONG FIRST USERS OF EACH MOLECULE

10. OP0220 SECULAR TRENDS IN BASELINE CHARACTERISTICS, TREATMENT RETENTION AND RESPONSE RATES IN 17453 BIONAÏVE PSORIATIC ARTHRITIS PATIENTS INITIATING TNFI – RESULTS FROM THE EUROSPA COLLABORATION

11. OP0014 COMPARISON OF ANTERIOR UVEITIS OCCURRENCE DURING TREATMENT WITH SECUKINUMAB, ADALIMUMAB, INFLIXIMAB AND ETANERCEPT IN SPONDYLOARTHRITIS

12. THU0394 COMPARISON OF TREATMENT RETENTION OF SECUKINUMAB AND TNF-INHIBITORS IN PSORIATIC ARTHRITIS. OBSERVATIONAL DATA FROM A NORDIC COLLABORATION

13. THU0303 TREATMENT OF GIANT CELL ARTERITIS WITH TOCILIZUMAB IN CLINICAL PRACTICE IN SWEDEN

14. AB0846 HIGH DEGREE OF CLASSIFICATION CRITERIA FULFILLMENT AMONG PATIENTS WITH CLINICAL PSORIATIC ARTHRITIS DIAGNOSES IN SWEDEN

15. FRI0283 CO-MEDICATION WITH CSDMARD HAS LITTLE EFFECT ON THE RETENTION OF TNF INHIBITORS IN PSORIATIC ARTHRITIS, RESULTS FROM THE EUROSPA COLLABORATION

16. FRI0534 PATIENT-REPORTED MEASURES OF DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS VARY ACROSS THE NORDIC COUNTRIES, RESULTS FROM A NORDIC COLLABORATION

17. Comparison of agreement between internet-based registration of patient-reported outcomes and clinic-based paper forms within the Swedish Rheumatology Quality Register

18. THU0196 Do contextual factors influence survival ondrug of biosimilars in clinical practice?

19. FRI0213 Comparative effectiveness of abatacept, rituximab, tocilizumab and anti-tnf biological dmards in ra: results from the nationwide swedish register

20. OP0200 Confounding by indication will make NON-TNFI BDMARDS appear more harmful than TNFI bdmards - a nationwide study of channeling in sweden 2010-2014

21. FRI0518 Prescription patterns of tumour necrosis factor inhibitor and ustekinumab in psoriatic arthritis: a nordic population-based cohort study

22. THU0632 Validation of internet-based reporting of patient reported outcomes within the swedish rheumatology quality register

23. THU0652 Assessment of biosimilars using real world data: the complexity of choosing a comparator and understanding uptake

24. Clinical Evaluation of the Efficacy of a Barrier Cream Containing Polyvinylpyrrolidone in Chronic Hand Eczema

25. THU0605 Omega-3 Fatty Acids Associates with Decreased Pain, Independent of Inflammation, in MTX Treated Early RA Patients

26. THU0608 Visualization and Analysis Platform in The Swedish Rheumatology Register for Real-Time Data Feedback

27. THU0158 Which Patient Characteristics Influence The Choice of Biological Therapy after First TNF Inhibitor Therapy in RA? A Nationwide Study of Channeling in Sweden 2010-2012

28. AB0118 Physical Activity and Risk of Rheumatoid Arthritis in Women